Bridging Data and Recovery NTP Provider Education Presentation

Faculty

Target Audience

The target audience for this course includes physicians, advanced practice providers, pharmacists, nurses, and any other individuals who participate in the prevention and treatment of substance use disorders and sustained recovery.

Objectives

Upon completion of the educational activity, participants will be able to:

1. Understanding KASPER * What is KASPER (Kentucky All Schedule Prescription Electronic Reporting)? * How to use KASPER to make safer clinical decisions. * Using data to see patterns in controlled substance use and improve prescribing.

2. Improving Patient Care for Substance Use Disorder (SUD) * An overview of Medication for Opioid Use Disorder (MOUD). * Practical ways to reduce stigma for patients receiving treatment. * Best practices for documentation and communication when prescribing controlled substances.

3. Staying Compliant and Working Together * A review of key Kentucky regulations. * The importance of ongoing education and collaboration with Narcotic Treatment Providers.

Accreditation

In support of improving patient care, this activity has been planned and implemented by UK HealthCare CECentral and Kentucky Office of Inspector General (OS). University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CME
This enduring material is designated for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This training has been approved by the KBML as meeting the statutory requirements of HB1. 0625-H1.0-UKHC8D

CPE
This knowledge-based activity will award 0.75 contact hours (0.075 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Other
UK Healthcare CECentral certifies this activity for 0.75 hours of participation.

CNE
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 nursing contact hours.

Faculty Disclosure

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months.  An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company. 

None of the planners, faculty, and others in control of educational content for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgement

This activity is jointly provided by the University of Kentucky and Kentucky Office of Inspector General (OS).